In contrast, KLA-5-FU/PTX Lps successfully inhibited tumor growth by 81% compared to only 34.69% for 5-FU/PTX or 61.8% for 5-FU/PTX Lps (Figure 11A,C). This evidence concerns the gene KL and neoplasm.